Featured Research

Journal Article

GLP-1 Therapy and the Reshaping of Socioeconomic Gradients in Health

GLP-1s may deliver the greatest health and economic benefits to disadvantaged populations, who historically have faced greater challenges losing weight through behavioral interventions.

Prevention
Public Health

Featured Experts: J. Felipe Montano-Campos, Bryan Tysinger, Dana Goldman, Darius Lakdawalla

All Research

Latest Research View All

GLP-1 Therapy and the Reshaping of Socioeconomic Gradients in Health

Medicare’s $35 Insulin Cap Lowered Beneficiary Costs, Increased Use for Some

Comments on the Commissioner’s National Priority Voucher Pilot Program

How Medicare’s Evidence Requirements Create Barriers to Equitable Healthcare Access

In The News View All

Schiller urges FDA to establish formal procedures for commissioner’s voucher program

Chen warns MFN could have unintended consequences and highlights need for US value-based pricing

Qato discusses her pharmacy mapping tool, revealing where access has collapsed

Mulligan explains how 340B program encourages hospitals to favor more expensive drugs

Kanter addresses psychedelics executive order and outlines concerns with the FDA commissioner’s voucher program

Featured White Paper

Fixing Medicare Advantage With Competitive Bidding

Medicare Advantage View All

MedPAC Findings Versus the Insurance Industry: Is MA Paid More Than Traditional Medicare?

The Changing Part D Landscape

Medicare is Experimenting With Having AI Review Claims

Comments on How to Improve and Modernize Medicare Advantage

In The News View All

Ginsburg says stricter oversight of Medicare Advantage payments has been working as intended

Trish interviewed on rising Medicare drug plan costs and narrowing options

CMS staffing shortages could make the Medicare enrollment season challenging for beneficiaries, Blum warns

Lieberman discusses the meteoric rise of Medicare Advantage and possible reforms

Do Medicare Advantage Provider Networks Change the Way Beneficiaries Use Health Care?